Terms: = Bone cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
9 results:
1. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
3. Successful chemotherapy with continuous immunotherapy for primary pulmonary endovascular epithelioid hemangioendothelioma: A case report.
Guo W; Zhou D; Huang H; Chen H; Wu X; Yang X; Ye H; Hong C
Medicine (Baltimore); 2023 Feb; 102(7):e32914. PubMed ID: 36800635
[TBL] [Abstract] [Full Text] [Related]
4. FAT1 and msh2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic treatment.
Zhou C; Sun Y; Gong Z; Li J; Zhao X; Yang Q; Yu H; Ye J; Liang J; Jiang L; Zhang D; Shen Z; Zheng S
J Bone Miner Res; 2022 May; 37(5):885-895. PubMed ID: 35279875
[TBL] [Abstract] [Full Text] [Related]
5. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
[TBL] [Abstract] [Full Text] [Related]
6. Bilateral pleural effusion associated with atezolizumab in a patient with Lynch syndrome-related urothelial carcinoma: a case report.
Yhim HY; Jeon SY; Lee CH; Lee NR
Ann Palliat Med; 2022 Jun; 11(6):2162-2169. PubMed ID: 34328007
[TBL] [Abstract] [Full Text] [Related]
7. LuCaP Prostate cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating cancer Therapeutics.
Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
[TBL] [Abstract] [Full Text] [Related]
8. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
[TBL] [Abstract] [Full Text] [Related]
9. Functional and physical interaction between the mismatch repair and FA-BRCA pathways.
Williams SA; Wilson JB; Clark AP; Mitson-Salazar A; Tomashevski A; Ananth S; Glazer PM; Semmes OJ; Bale AE; Jones NJ; Kupfer GM
Hum Mol Genet; 2011 Nov; 20(22):4395-410. PubMed ID: 21865299
[TBL] [Abstract] [Full Text] [Related]
